Tilray medical receives approval for first medical cannabis extract in portugal

Cantanhede, portugal, march 14, 2024 (globe newswire) -- tilray brands, inc. (“tilray” or the “company”) (nasdaq: tlry; tsx: tlry), a leading global cannabis and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced a groundbreaking achievement in the medical cannabis industry in portugal. following the successful approval of our tilray whole flower thc 18, tilray medical has now received approval for the first medical cannabis extract, tilray oral solution thc 5 cbd 20, in portugal, marking a significant milestone in medical cannabis availability and patient care within the country.
TLRY Ratings Summary
TLRY Quant Ranking